Longterm Follow-up of Subjects Treated With bb2121
NCT02786511
·
clinicaltrials.gov ↗
COMPLETED
Status
50
Enrollment
INDUSTRY
Sponsor class
Conditions
Multiple Myeloma
Interventions
DRUG:
Safety and efficacy assessments
Sponsor
Celgene